Witch Hazel Pore Clarifying Toner

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided.

Uses and Indications

This drug is indicated for the treatment of acne vulgaris. It effectively clears existing acne blemishes and penetrates pores to control the formation of acne lesions. Additionally, this drug helps prevent the emergence of new acne blemishes.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleansed prior to the application of the medication. The medication should be applied as a thin layer to the entire affected area. Initial dosing should consist of one application daily, with the possibility of increasing to two or three times daily based on clinical response or as directed by a physician.

It is recommended to use a cotton ball or pad for application to ensure even coverage. In cases where bothersome dryness or peeling occurs, the frequency of application should be reduced to once daily or every other day to mitigate these side effects.

Contraindications

There are no contraindications listed for this product. However, it is imperative to seek medical assistance or contact a poison control center immediately if the product is swallowed.

Warnings and Precautions

This product is intended for external use only. It is important to note that the formulation is flammable; therefore, it should be kept away from fire or flame to prevent any hazardous incidents.

When utilizing this product, healthcare professionals should be aware that the likelihood of skin irritation and dryness may increase if another topical acne medication is used concurrently. To mitigate the risk of irritation, it is advisable to limit the use to one topical acne medication at a time. Additionally, care should be taken to avoid contact with the eyes. In the event of accidental contact, it is essential to rinse the eyes thoroughly with water to minimize potential adverse effects.

In cases of ingestion, immediate medical assistance should be sought. If the product is swallowed, it is crucial to contact a poison control center or seek emergency medical help without delay.

Healthcare professionals are encouraged to monitor patients for any signs of adverse reactions and to provide guidance on the appropriate use of this product to ensure safety and efficacy.

Side Effects

Patients using this product should be aware that it is for external use only and is flammable; therefore, it should be kept away from fire or flame.

In clinical practice, skin irritation and dryness have been reported as common adverse reactions, particularly when this product is used concurrently with other topical acne medications. To minimize the risk of irritation, it is advised that patients use only one topical acne medication at a time.

Additionally, care should be taken to avoid contact with the eyes. In the event of accidental contact, it is recommended that the affected area be rinsed thoroughly with water to alleviate any potential discomfort.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the products is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Witch Hazel Pore Clarifying Toner (salicylic acid 2%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a poison control center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no information available regarding the use of Witch Hazel Pore Clarifying Toner during pregnancy. The drug insert does not provide safety concerns, dosage modifications, or special precautions for pregnant patients. Therefore, healthcare professionals should exercise caution when recommending this product to women of childbearing potential, as the potential effects on fetal outcomes are not established. It is advisable to consider alternative options or consult with a healthcare provider for further guidance.

Lactation

There is no specific information regarding nursing mothers or lactation considerations provided in the drug insert for Witch Hazel Pore Clarifying Toner. Therefore, healthcare professionals should exercise caution and consider the lack of data when advising lactating mothers on the use of this product. The potential effects on breastfed infants are not established, and further research may be necessary to determine safety during lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from excessive dosing. Symptoms of overdosage can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide further management and intervention strategies.

Documentation of the incident, including the amount ingested and the time of exposure, is crucial for effective treatment planning.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event that the medication is swallowed, patients should be instructed to seek medical help or contact a poison control center immediately. It is essential for patients to understand the importance of these precautions to ensure their safety and the safety of others.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. No special handling requirements are noted; however, standard precautions should be observed to ensure optimal storage conditions.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Witch Hazel Pore Clarifying Toner, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)